In contrast to the CD8+ cytotoxic T cells which are the most powerful effectors in the anticancer immune response, the exact mechanism of how CD4+ T cells are involved in the anti-tumour immunity is less clear [57–60]. This evidence concerns the gene CD8A and neoplasm.